Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 3560920, 6 pages
https://doi.org/10.1155/2017/3560920
Research Article

Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients

1Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China
2Graduate School of Peking Union Medical College, Beijing, China
3Beijing Key Lab Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, China
4Department of Pathophysiology, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, China

Correspondence should be addressed to Ping Li; moc.361@5768pl and YongTong Cao; moc.621@86gnotgnoyoac

Received 10 September 2016; Revised 2 January 2017; Accepted 29 January 2017; Published 23 February 2017

Academic Editor: Kezhong Zhang

Copyright © 2017 YongWei Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. R. Tuttle, G. L. Bakris, R. W. Bilous et al., “Diabetic kidney disease: a report from an ADA consensus conference,” American Journal of Kidney Diseases, vol. 64, no. 4, pp. 510–533, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Zhang, S. Efendic, K. Brismar, and H. F. Gu, “Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 diabetes mellitus,” BMC Medical Genetics, vol. 11, no. 1, article 116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. ADVANCE Collaborative Group, A. Patel, S. Macmahon et al., “Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 358, no. 3, pp. 2560–2572, 2008. View at Publisher · View at Google Scholar
  4. E. R. Seaquist, F. C. Goetz, S. Rich, and J. Barbosa, “Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy,” New England Journal of Medicine, vol. 320, no. 18, pp. 1161–1165, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Pettitt, M. F. Saad, P. H. Bennett, R. G. Nelson, and W. C. Knowler, “Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus,” Diabetologia, vol. 33, no. 7, pp. 438–443, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Quinn, M. C. Angelico, J. H. Warram, and A. S. Krolewski, “Familial factors determine the development of diabetic nephropathy in patients with IDDM,” Diabetologia, vol. 39, no. 8, pp. 940–945, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. P. K. Chandie Shaw, F. Baboe, L. A. Van Es et al., “South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients,” Diabetes Care, vol. 29, no. 6, pp. 1383–1385, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. C. Y. Ng, L. Baum, W.-Y. So et al., “Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3-455T>C polymorphisms on the susceptibility to diabetic nephropathy,” Clinical Genetics, vol. 70, no. 1, pp. 20–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. V. N. Shah, B. S. Cheema, R. Sharma et al., “ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes,” Molecular and Cellular Biochemistry, vol. 372, no. 1-2, pp. 191–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. L. S.-H. Wu, C.-H. Hsieh, D. Pei, Y.-J. Hung, S.-W. Kuo, and E. Lin, “Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARγ and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes,” Nephrology Dialysis Transplantation, vol. 24, no. 11, pp. 3360–3366, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. R. W. Mahley, “Apolipoprotein E: cholesterol transport protein with expanding role in cell biology,” Science, vol. 240, no. 4852, pp. 622–630, 1988. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Demant, D. Bedford, C. J. Packard, and J. Shepherd, “Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects,” Journal of Clinical Investigation, vol. 88, no. 5, pp. 1490–1501, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Gañán, D. Corella, M. Guillén, J. M. Ordovás, and M. Pocovít, “Frequencies of apolipoprotein A4 gene polymorphisms and association with serum lipid concentrations in two healthy Spanish populations,” Human Biology, vol. 76, no. 2, pp. 253–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S.-K. Ha, H. S. Park, K. W. Kim et al., “Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus,” Nephrology Dialysis Transplantation, vol. 14, no. 9, pp. 2144–2149, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. R. G. Nelson, J. M. Newman, W. C. Knowler et al., “Incidence of end-stage renal disease in Type 2 (non-insulin-dependent) diabetes mellitus in pima indians,” Diabetologia, vol. 31, no. 10, pp. 730–736, 1988. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Yang, J. Lu, J. Weng et al., “Prevalence of diabetes among men and women in China,” New England Journal of Medicine, vol. 362, no. 12, pp. 1090–1101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. L. Mooyaart, E. J. Valk, L. A. van Es et al., “Erratum to: genetic associations in diabetic nephropathy: a meta-analysis,” Diabetologia, vol. 57, no. 3, pp. 544–553, 2014. View at Google Scholar
  18. M. Eto, M. Saito, M. Okada et al., “Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients,” American Journal of Kidney Diseases, vol. 40, no. 2, pp. 243–251, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Li, K. Tang, Z. Zhang et al., “Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis,” Molecular Biology Reports, vol. 38, no. 5, pp. 3243–3252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. L. Mooyaart, E. J. Valk, L. A. van Es et al., “Genetic associations in diabetic nephropathy: a meta-analysis,” Diabetologia, vol. 57, no. 3, p. 650, 2014. View at Google Scholar
  21. M. Eto, K. Horita, A. Morikawa et al., “Increased frequency of apolipoprotein ε2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy,” Clinical Genetics, vol. 48, no. 6, pp. 288–292, 1995. View at Google Scholar · View at Scopus
  22. T. Li, Y. Shi, J. Yin et al., “The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis,” International Urology and Nephrology, vol. 47, no. 1, pp. 117–130, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-W. Yin, L. Qiao, Q.-Q. Sun et al., “Influence of apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies,” Metabolism: Clinical and Experimental, vol. 63, no. 4, pp. 532–541, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Boize, P.-Y. Benhamou, P. Corticelli, K. Valenti, J.-L. Bosson, and S. Halimi, “ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?” Nephrology Dialysis Transplantation, vol. 13, no. 1, pp. 72–75, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Erdogan, Z. Eroglu, C. Biray et al., “The relationship of the apolipoprotein e gene polymorphism in Turkish Type 2 diabetic patients with and without nephropathy,” Journal of Endocrinological Investigation, vol. 32, no. 3, pp. 219–222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K.-J. Tien, S.-T. Tu, C.-W. Chou et al., “Apolipoprotein e polymorphism and the progression of diabetic nephropathy in type 2 diabetes,” American Journal of Nephrology, vol. 33, no. 3, pp. 231–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Horita, M. Eto, and I. Makino, “Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus,” Atherosclerosis, vol. 107, no. 2, pp. 203–211, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-I. Araki, “APOE polymorphism and diabetic nephropathy,” Clinical and Experimental Nephrology, vol. 18, no. 2, pp. 230–233, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kimura, Y. Suzuki, F. Gejyo et al., “Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM,” American Journal of Kidney Diseases, vol. 31, no. 4, pp. 666–673, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Onuma, L. M. B. Laffel, M. C. Angelico et al., “Apolipoprotein E genotype and risk of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 7, no. 7, pp. 1075–1078, 1996. View at Google Scholar
  31. K. S. L. Lam, I. K. P. Cheng, E. D. Janus, and R. W. C. Pang, “Cholesterol-lowering therapy may retard the progression of diabetic nephropathy,” Diabetologia, vol. 38, no. 5, pp. 604–609, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Ukkola, K. Kervinen, P. I. Salmela, K. von Dickhoff, M. Laakso, and Y. A. Kesäniemi, “Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus,” Atherosclerosis, vol. 101, no. 1, pp. 9–15, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Chen, L. Paka, Y. Kako, P. Singhal, W. Duan, and S. Pillarisetti, “A protective role for kidney apolipoprotein E: regulation of mesangial cell proliferation and matrix expansion,” Journal of Biological Chemistry, vol. 276, no. 52, pp. 49142–49147, 2001. View at Publisher · View at Google Scholar · View at Scopus